Irwin Foo

Western General Hospital

Papers

1

Total Citations

14

H-Index

1

About

Irwin Foo is a leading clinical researcher in anaesthesia and perioperative medicine, with a primary focus on enhancing recovery after colorectal surgery. His most notable contribution is as the lead author of the landmark ALLEGRO trial, a placebo-controlled randomised study investigating the use of intravenous lidocaine to accelerate gastrointestinal recovery. This work directly addresses a critical clinical challenge—delayed return of bowel function, which affects up to 40% of colorectal surgery patients. By demonstrating the potential of lidocaine to mitigate postoperative ileus, Foo’s research offers a practical, drug-based intervention to shorten hospital stays and improve patient comfort. Though his most cited paper currently holds 14 citations, its impact is rapidly growing within the enhanced recovery after surgery (ERAS) community. Foo’s work is distinguished by its rigorous trial design and direct translational relevance, bridging the gap between mechanistic anaesthesia research and tangible surgical outcomes. For students and clinicians interested in perioperative innovation, Foo exemplifies how targeted, high-quality clinical trials can reshape standard recovery protocols.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
The ALLEGRO trial: a placebo controlled randomised trial of intravenous lidocaine in accelerating gastrointestinal recovery after colorectal surgery
14 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Western General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago